The global Non Alcoholic Steatohepatitis Treatment market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Vitamin E And Pioglitazone Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Non Alcoholic Steatohepatitis Treatment include AstraZeneca Plc., Tobira Therapeutics Inc., Galmed Pharmaceuticals, Genfit SA, Zydus Cadila, Bristol Myers Squibb, Gilead Science, Conatus Pharmaceuticals Inc. and Novo Nordisk A/S, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Non Alcoholic Steatohepatitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non Alcoholic Steatohepatitis Treatment. This report contains market size and forecasts of Non Alcoholic Steatohepatitis Treatment in global, including the following market information:
Global Non Alcoholic Steatohepatitis Treatment Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Non Alcoholic Steatohepatitis Treatment Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Non Alcoholic Steatohepatitis Treatment companies in 2023 (%)
We surveyed the Non Alcoholic Steatohepatitis Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non Alcoholic Steatohepatitis Treatment Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Non Alcoholic Steatohepatitis Treatment Market Segment Percentages, by Type, 2023 (%)
Vitamin E And Pioglitazone
Ocaliva
Elafibranor
Obeticholic Acid
Global Non Alcoholic Steatohepatitis Treatment Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Non Alcoholic Steatohepatitis Treatment Market Segment Percentages, by Application, 2023 (%)
Hospital Pharmacies
Retail And Specialty Pharmacies
Global Non Alcoholic Steatohepatitis Treatment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Non Alcoholic Steatohepatitis Treatment Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non Alcoholic Steatohepatitis Treatment revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Non Alcoholic Steatohepatitis Treatment revenues share in global market, 2023 (%)
Key companies Non Alcoholic Steatohepatitis Treatment sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Non Alcoholic Steatohepatitis Treatment sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca Plc.
Tobira Therapeutics Inc.
Galmed Pharmaceuticals
Genfit SA
Zydus Cadila
Bristol Myers Squibb
Gilead Science
Conatus Pharmaceuticals Inc.
Novo Nordisk A/S
Immuron Ltd.
Raptor Pharmaceutical Corporation
Inventiva Pharma
NGM Biopharmaceuticals Inc.
Galectin Therapeutics Inc.
Madrigal Pharmaceuticals
Gemphire Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non Alcoholic Steatohepatitis Treatment, market overview.
Chapter 2: Global Non Alcoholic Steatohepatitis Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Non Alcoholic Steatohepatitis Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non Alcoholic Steatohepatitis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Non Alcoholic Steatohepatitis Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Non Alcoholic Steatohepatitis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non Alcoholic Steatohepatitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non Alcoholic Steatohepatitis Treatment Overall Market Size
2.1 Global Non Alcoholic Steatohepatitis Treatment Market Size: 2023 VS 2030
2.2 Global Non Alcoholic Steatohepatitis Treatment Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Non Alcoholic Steatohepatitis Treatment Sales: 2019-2030
3 Company Landscape
3.1 Top Non Alcoholic Steatohepatitis Treatment Players in Global Market
3.2 Top Global Non Alcoholic Steatohepatitis Treatment Companies Ranked by Revenue
3.3 Global Non Alcoholic Steatohepatitis Treatment Revenue by Companies
3.4 Global Non Alcoholic Steatohepatitis Treatment Sales by Companies
3.5 Global Non Alcoholic Steatohepatitis Treatment Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Non Alcoholic Steatohepatitis Treatment Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Non Alcoholic Steatohepatitis Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non Alcoholic Steatohepatitis Treatment Players in Global Market
3.8.1 List of Global Tier 1 Non Alcoholic Steatohepatitis Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Non Alcoholic Steatohepatitis Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Non Alcoholic Steatohepatitis Treatment Market Size Markets, 2023 & 2030
4.1.2 Vitamin E And Pioglitazone
4.1.3 Ocaliva
4.1.4 Elafibranor
4.1.5 Obeticholic Acid
4.2 By Type - Global Non Alcoholic Steatohepatitis Treatment Revenue & Forecasts
4.2.1 By Type - Global Non Alcoholic Steatohepatitis Treatment Revenue, 2019-2024
4.2.2 By Type - Global Non Alcoholic Steatohepatitis Treatment Revenue, 2025-2030
4.2.3 By Type - Global Non Alcoholic Steatohepatitis Treatment Revenue Market Share, 2019-2030
4.3 By Type - Global Non Alcoholic Steatohepatitis Treatment Sales & Forecasts
4.3.1 By Type - Global Non Alcoholic Steatohepatitis Treatment Sales, 2019-2024
4.3.2 By Type - Global Non Alcoholic Steatohepatitis Treatment Sales, 2025-2030
4.3.3 By Type - Global Non Alcoholic Steatohepatitis Treatment Sales Market Share, 2019-2030
4.4 By Type - Global Non Alcoholic Steatohepatitis Treatment Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non Alcoholic Steatohepatitis Treatment Market Size, 2023 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail And Specialty Pharmacies
5.2 By Application - Global Non Alcoholic Steatohepatitis Treatment Revenue & Forecasts
5.2.1 By Application - Global Non Alcoholic Steatohepatitis Treatment Revenue, 2019-2024
5.2.2 By Application - Global Non Alcoholic Steatohepatitis Treatment Revenue, 2025-2030
5.2.3 By Application - Global Non Alcoholic Steatohepatitis Treatment Revenue Market Share, 2019-2030
5.3 By Application - Global Non Alcoholic Steatohepatitis Treatment Sales & Forecasts
5.3.1 By Application - Global Non Alcoholic Steatohepatitis Treatment Sales, 2019-2024
5.3.2 By Application - Global Non Alcoholic Steatohepatitis Treatment Sales, 2025-2030
5.3.3 By Application - Global Non Alcoholic Steatohepatitis Treatment Sales Market Share, 2019-2030
5.4 By Application - Global Non Alcoholic Steatohepatitis Treatment Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Non Alcoholic Steatohepatitis Treatment Market Size, 2023 & 2030
6.2 By Region - Global Non Alcoholic Steatohepatitis Treatment Revenue & Forecasts
6.2.1 By Region - Global Non Alcoholic Steatohepatitis Treatment Revenue, 2019-2024
6.2.2 By Region - Global Non Alcoholic Steatohepatitis Treatment Revenue, 2025-2030
6.2.3 By Region - Global Non Alcoholic Steatohepatitis Treatment Revenue Market Share, 2019-2030
6.3 By Region - Global Non Alcoholic Steatohepatitis Treatment Sales & Forecasts
6.3.1 By Region - Global Non Alcoholic Steatohepatitis Treatment Sales, 2019-2024
6.3.2 By Region - Global Non Alcoholic Steatohepatitis Treatment Sales, 2025-2030
6.3.3 By Region - Global Non Alcoholic Steatohepatitis Treatment Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Non Alcoholic Steatohepatitis Treatment Revenue, 2019-2030
6.4.2 By Country - North America Non Alcoholic Steatohepatitis Treatment Sales, 2019-2030
6.4.3 US Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.4.4 Canada Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.4.5 Mexico Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Non Alcoholic Steatohepatitis Treatment Revenue, 2019-2030
6.5.2 By Country - Europe Non Alcoholic Steatohepatitis Treatment Sales, 2019-2030
6.5.3 Germany Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.5.4 France Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.5.5 U.K. Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.5.6 Italy Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.5.7 Russia Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.5.8 Nordic Countries Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.5.9 Benelux Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Non Alcoholic Steatohepatitis Treatment Revenue, 2019-2030
6.6.2 By Region - Asia Non Alcoholic Steatohepatitis Treatment Sales, 2019-2030
6.6.3 China Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.6.4 Japan Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.6.5 South Korea Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.6.6 Southeast Asia Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.6.7 India Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Non Alcoholic Steatohepatitis Treatment Revenue, 2019-2030
6.7.2 By Country - South America Non Alcoholic Steatohepatitis Treatment Sales, 2019-2030
6.7.3 Brazil Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.7.4 Argentina Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Non Alcoholic Steatohepatitis Treatment Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Non Alcoholic Steatohepatitis Treatment Sales, 2019-2030
6.8.3 Turkey Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.8.4 Israel Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.8.5 Saudi Arabia Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
6.8.6 UAE Non Alcoholic Steatohepatitis Treatment Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 AstraZeneca Plc.
7.1.1 AstraZeneca Plc. Company Summary
7.1.2 AstraZeneca Plc. Business Overview
7.1.3 AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Major Product Offerings
7.1.4 AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Sales and Revenue in Global (2019-2024)
7.1.5 AstraZeneca Plc. Key News & Latest Developments
7.2 Tobira Therapeutics Inc.
7.2.1 Tobira Therapeutics Inc. Company Summary
7.2.2 Tobira Therapeutics Inc. Business Overview
7.2.3 Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Major Product Offerings
7.2.4 Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Sales and Revenue in Global (2019-2024)
7.2.5 Tobira Therapeutics Inc. Key News & Latest Developments
7.3 Galmed Pharmaceuticals
7.3.1 Galmed Pharmaceuticals Company Summary
7.3.2 Galmed Pharmaceuticals Business Overview
7.3.3 Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Major Product Offerings
7.3.4 Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Sales and Revenue in Global (2019-2024)
7.3.5 Galmed Pharmaceuticals Key News & Latest Developments
7.4 Genfit SA
7.4.1 Genfit SA Company Summary
7.4.2 Genfit SA Business Overview
7.4.3 Genfit SA Non Alcoholic Steatohepatitis Treatment Major Product Offerings
7.4.4 Genfit SA Non Alcoholic Steatohepatitis Treatment Sales and Revenue in Global (2019-2024)
7.4.5 Genfit SA Key News & Latest Developments
7.5 Zydus Cadila
7.5.1 Zydus Cadila Company Summary
7.5.2 Zydus Cadila Business Overview
7.5.3 Zydus Cadila Non Alcoholic Steatohepatitis Treatment Major Product Offerings
7.5.4 Zydus Cadila Non Alcoholic Steatohepatitis Treatment Sales and Revenue in Global (2019-2024)
7.5.5 Zydus Cadila Key News & Latest Developments
7.6 Bristol Myers Squibb
7.6.1 Bristol Myers Squibb Company Summary
7.6.2 Bristol Myers Squibb Business Overview
7.6.3 Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Major Product Offerings
7.6.4 Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Sales and Revenue in Global (2019-2024)
7.6.5 Bristol Myers Squibb Key News & Latest Developments
7.7 Gilead Science
7.7.1 Gilead Science Company Summary
7.7.2 Gilead Science Business Overview
7.7.3 Gilead Science Non Alcoholic Steatohepatitis Treatment Major Product Offerings
7.7.4 Gilead Science Non Alcoholic Steatohepatitis Treatment Sales and Revenue in Global (2019-2024)
7.7.5 Gilead Science Key News & Latest Developments
7.8 Conatus Pharmaceuticals Inc.
7.8.1 Conatus Pharmaceuticals Inc. Company Summary
7.8.2 Conatus Pharmaceuticals Inc. Business Overview
7.8.3 Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Major Product Offerings
7.8.4 Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Sales and Revenue in Global (2019-2024)
7.8.5 Conatus Pharmaceuticals Inc. Key News & Latest Developments
7.9 Novo Nordisk A/S
7.9.1 Novo Nordisk A/S Company Summary
7.9.2 Novo Nordisk A/S Business Overview
7.9.3 Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Major Product Offerings
7.9.4 Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Sales and Revenue in Global (2019-2024)
7.9.5 Novo Nordisk A/S Key News & Latest Developments
7.10 Immuron Ltd.
7.10.1 Immuron Ltd. Company Summary
7.10.2 Immuron Ltd. Business Overview
7.10.3 Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Major Product Offerings
7.10.4 Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Sales and Revenue in Global (2019-2024)
7.10.5 Immuron Ltd. Key News & Latest Developments
7.11 Raptor Pharmaceutical Corporation
7.11.1 Raptor Pharmaceutical Corporation Company Summary
7.11.2 Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Business Overview
7.11.3 Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Major Product Offerings
7.11.4 Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Sales and Revenue in Global (2019-2024)
7.11.5 Raptor Pharmaceutical Corporation Key News & Latest Developments
7.12 Inventiva Pharma
7.12.1 Inventiva Pharma Company Summary
7.12.2 Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Business Overview
7.12.3 Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Major Product Offerings
7.12.4 Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Sales and Revenue in Global (2019-2024)
7.12.5 Inventiva Pharma Key News & Latest Developments
7.13 NGM Biopharmaceuticals Inc.
7.13.1 NGM Biopharmaceuticals Inc. Company Summary
7.13.2 NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Business Overview
7.13.3 NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Major Product Offerings
7.13.4 NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Sales and Revenue in Global (2019-2024)
7.13.5 NGM Biopharmaceuticals Inc. Key News & Latest Developments
7.14 Galectin Therapeutics Inc.
7.14.1 Galectin Therapeutics Inc. Company Summary
7.14.2 Galectin Therapeutics Inc. Business Overview
7.14.3 Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Major Product Offerings
7.14.4 Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Sales and Revenue in Global (2019-2024)
7.14.5 Galectin Therapeutics Inc. Key News & Latest Developments
7.15 Madrigal Pharmaceuticals
7.15.1 Madrigal Pharmaceuticals Company Summary
7.15.2 Madrigal Pharmaceuticals Business Overview
7.15.3 Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Major Product Offerings
7.15.4 Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Sales and Revenue in Global (2019-2024)
7.15.5 Madrigal Pharmaceuticals Key News & Latest Developments
7.16 Gemphire Therapeutics
7.16.1 Gemphire Therapeutics Company Summary
7.16.2 Gemphire Therapeutics Business Overview
7.16.3 Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Major Product Offerings
7.16.4 Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Sales and Revenue in Global (2019-2024)
7.16.5 Gemphire Therapeutics Key News & Latest Developments
8 Global Non Alcoholic Steatohepatitis Treatment Production Capacity, Analysis
8.1 Global Non Alcoholic Steatohepatitis Treatment Production Capacity, 2019-2030
8.2 Non Alcoholic Steatohepatitis Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Non Alcoholic Steatohepatitis Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non Alcoholic Steatohepatitis Treatment Supply Chain Analysis
10.1 Non Alcoholic Steatohepatitis Treatment Industry Value Chain
10.2 Non Alcoholic Steatohepatitis Treatment Upstream Market
10.3 Non Alcoholic Steatohepatitis Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non Alcoholic Steatohepatitis Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Non Alcoholic Steatohepatitis Treatment in Global Market
Table 2. Top Non Alcoholic Steatohepatitis Treatment Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Non Alcoholic Steatohepatitis Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Non Alcoholic Steatohepatitis Treatment Revenue Share by Companies, 2019-2024
Table 5. Global Non Alcoholic Steatohepatitis Treatment Sales by Companies, (K Units), 2019-2024
Table 6. Global Non Alcoholic Steatohepatitis Treatment Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Non Alcoholic Steatohepatitis Treatment Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Non Alcoholic Steatohepatitis Treatment Product Type
Table 9. List of Global Tier 1 Non Alcoholic Steatohepatitis Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non Alcoholic Steatohepatitis Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Non Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Non Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Non Alcoholic Steatohepatitis Treatment Sales (K Units), 2019-2024
Table 15. By Type - Global Non Alcoholic Steatohepatitis Treatment Sales (K Units), 2025-2030
Table 16. By Application ? Global Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Non Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Non Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Non Alcoholic Steatohepatitis Treatment Sales (K Units), 2019-2024
Table 20. By Application - Global Non Alcoholic Steatohepatitis Treatment Sales (K Units), 2025-2030
Table 21. By Region ? Global Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Non Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Non Alcoholic Steatohepatitis Treatment Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Non Alcoholic Steatohepatitis Treatment Sales (K Units), 2019-2024
Table 25. By Region - Global Non Alcoholic Steatohepatitis Treatment Sales (K Units), 2025-2030
Table 26. By Country - North America Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Non Alcoholic Steatohepatitis Treatment Sales, (K Units), 2019-2024
Table 29. By Country - North America Non Alcoholic Steatohepatitis Treatment Sales, (K Units), 2025-2030
Table 30. By Country - Europe Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Non Alcoholic Steatohepatitis Treatment Sales, (K Units), 2019-2024
Table 33. By Country - Europe Non Alcoholic Steatohepatitis Treatment Sales, (K Units), 2025-2030
Table 34. By Region - Asia Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Non Alcoholic Steatohepatitis Treatment Sales, (K Units), 2019-2024
Table 37. By Region - Asia Non Alcoholic Steatohepatitis Treatment Sales, (K Units), 2025-2030
Table 38. By Country - South America Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Non Alcoholic Steatohepatitis Treatment Sales, (K Units), 2019-2024
Table 41. By Country - South America Non Alcoholic Steatohepatitis Treatment Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Non Alcoholic Steatohepatitis Treatment Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Non Alcoholic Steatohepatitis Treatment Sales, (K Units), 2025-2030
Table 46. AstraZeneca Plc. Company Summary
Table 47. AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 48. AstraZeneca Plc. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. AstraZeneca Plc. Key News & Latest Developments
Table 50. Tobira Therapeutics Inc. Company Summary
Table 51. Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 52. Tobira Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Tobira Therapeutics Inc. Key News & Latest Developments
Table 54. Galmed Pharmaceuticals Company Summary
Table 55. Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 56. Galmed Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Galmed Pharmaceuticals Key News & Latest Developments
Table 58. Genfit SA Company Summary
Table 59. Genfit SA Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 60. Genfit SA Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Genfit SA Key News & Latest Developments
Table 62. Zydus Cadila Company Summary
Table 63. Zydus Cadila Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 64. Zydus Cadila Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Zydus Cadila Key News & Latest Developments
Table 66. Bristol Myers Squibb Company Summary
Table 67. Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 68. Bristol Myers Squibb Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Bristol Myers Squibb Key News & Latest Developments
Table 70. Gilead Science Company Summary
Table 71. Gilead Science Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 72. Gilead Science Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Gilead Science Key News & Latest Developments
Table 74. Conatus Pharmaceuticals Inc. Company Summary
Table 75. Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 76. Conatus Pharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Conatus Pharmaceuticals Inc. Key News & Latest Developments
Table 78. Novo Nordisk A/S Company Summary
Table 79. Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 80. Novo Nordisk A/S Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Novo Nordisk A/S Key News & Latest Developments
Table 82. Immuron Ltd. Company Summary
Table 83. Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 84. Immuron Ltd. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Immuron Ltd. Key News & Latest Developments
Table 86. Raptor Pharmaceutical Corporation Company Summary
Table 87. Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 88. Raptor Pharmaceutical Corporation Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Raptor Pharmaceutical Corporation Key News & Latest Developments
Table 90. Inventiva Pharma Company Summary
Table 91. Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 92. Inventiva Pharma Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Inventiva Pharma Key News & Latest Developments
Table 94. NGM Biopharmaceuticals Inc. Company Summary
Table 95. NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 96. NGM Biopharmaceuticals Inc. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. NGM Biopharmaceuticals Inc. Key News & Latest Developments
Table 98. Galectin Therapeutics Inc. Company Summary
Table 99. Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 100. Galectin Therapeutics Inc. Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Galectin Therapeutics Inc. Key News & Latest Developments
Table 102. Madrigal Pharmaceuticals Company Summary
Table 103. Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 104. Madrigal Pharmaceuticals Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. Madrigal Pharmaceuticals Key News & Latest Developments
Table 106. Gemphire Therapeutics Company Summary
Table 107. Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Product Offerings
Table 108. Gemphire Therapeutics Non Alcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 109. Gemphire Therapeutics Key News & Latest Developments
Table 110. Non Alcoholic Steatohepatitis Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 111. Global Non Alcoholic Steatohepatitis Treatment Capacity Market Share of Key Manufacturers, 2021-2024
Table 112. Global Non Alcoholic Steatohepatitis Treatment Production by Region, 2019-2024 (K Units)
Table 113. Global Non Alcoholic Steatohepatitis Treatment Production by Region, 2025-2030 (K Units)
Table 114. Non Alcoholic Steatohepatitis Treatment Market Opportunities & Trends in Global Market
Table 115. Non Alcoholic Steatohepatitis Treatment Market Drivers in Global Market
Table 116. Non Alcoholic Steatohepatitis Treatment Market Restraints in Global Market
Table 117. Non Alcoholic Steatohepatitis Treatment Raw Materials
Table 118. Non Alcoholic Steatohepatitis Treatment Raw Materials Suppliers in Global Market
Table 119. Typical Non Alcoholic Steatohepatitis Treatment Downstream
Table 120. Non Alcoholic Steatohepatitis Treatment Downstream Clients in Global Market
Table 121. Non Alcoholic Steatohepatitis Treatment Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Non Alcoholic Steatohepatitis Treatment Segment by Type in 2023
Figure 2. Non Alcoholic Steatohepatitis Treatment Segment by Application in 2023
Figure 3. Global Non Alcoholic Steatohepatitis Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Non Alcoholic Steatohepatitis Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Non Alcoholic Steatohepatitis Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. Non Alcoholic Steatohepatitis Treatment Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Non Alcoholic Steatohepatitis Treatment Revenue in 2023
Figure 9. By Type - Global Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Non Alcoholic Steatohepatitis Treatment Revenue Market Share, 2019-2030
Figure 11. By Type - Global Non Alcoholic Steatohepatitis Treatment Sales Market Share, 2019-2030
Figure 12. By Type - Global Non Alcoholic Steatohepatitis Treatment Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Non Alcoholic Steatohepatitis Treatment Revenue Market Share, 2019-2030
Figure 15. By Application - Global Non Alcoholic Steatohepatitis Treatment Sales Market Share, 2019-2030
Figure 16. By Application - Global Non Alcoholic Steatohepatitis Treatment Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Non Alcoholic Steatohepatitis Treatment Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Non Alcoholic Steatohepatitis Treatment Revenue Market Share, 2019-2030
Figure 20. By Region - Global Non Alcoholic Steatohepatitis Treatment Sales Market Share, 2019-2030
Figure 21. By Country - North America Non Alcoholic Steatohepatitis Treatment Revenue Market Share, 2019-2030
Figure 22. By Country - North America Non Alcoholic Steatohepatitis Treatment Sales Market Share, 2019-2030
Figure 23. US Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Non Alcoholic Steatohepatitis Treatment Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Non Alcoholic Steatohepatitis Treatment Sales Market Share, 2019-2030
Figure 28. Germany Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. France Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Non Alcoholic Steatohepatitis Treatment Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Non Alcoholic Steatohepatitis Treatment Sales Market Share, 2019-2030
Figure 37. China Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. India Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Non Alcoholic Steatohepatitis Treatment Revenue Market Share, 2019-2030
Figure 43. By Country - South America Non Alcoholic Steatohepatitis Treatment Sales Market Share, 2019-2030
Figure 44. Brazil Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Non Alcoholic Steatohepatitis Treatment Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Non Alcoholic Steatohepatitis Treatment Sales Market Share, 2019-2030
Figure 48. Turkey Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Non Alcoholic Steatohepatitis Treatment Revenue, (US$, Mn), 2019-2030
Figure 52. Global Non Alcoholic Steatohepatitis Treatment Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Non Alcoholic Steatohepatitis Treatment by Region, 2023 VS 2030
Figure 54. Non Alcoholic Steatohepatitis Treatment Industry Value Chain
Figure 55. Marketing Channels
